insulin aspart (NovoLog, Fiasp, Merilog)

From Aaushi
Jump to navigation Jump to search

Introduction

Synthetic proinsulin with more rapid onset & shorter duration of action than regular insulin, similar to insulin lispro.

Dosage

Pharmacokinetics

  • absorbed faster after SQ injection than insulin, but slightly slower than Humalog

Mechanism of action

Notes

Novo Nordisk manufacturer

More general terms

Additional terms

Component of

References

  1. Prescriber's Letter 8(2):supplement 2001
  2. Jump up to: 2.0 2.1 Prescriber's Letter 8(10):58 2001
  3. Monaco K FDA OKs First Rapid-Acting Insulin Biosimilar for Diabetes. Approval makes Merilog the third insulin biosimilar. MedPage Today February 14, 2025 https://www.medpagetoday.com/endocrinology/type1diabetes/114245